Aurobindo Pharma has received the approval from Health Canada for the 100mg, 300mg and 400mg of Gabapentin Capsules.
Gabapentin Capsules is the generic equivalent of Pfizer Canada Inc’s Neurontinl Capsules 100mg, 300mg and 400mg which falls under the CNS (Central Nervous System) segment and is used for the treatment of seizures in patients diagnosed with epilepsy.
This is Aurobindo’s sixth product approval from Health Canada.